Aimei Health Technology Co., Ltd
AFJK
$10.65
-$1.05-8.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 212.98% | -89.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 212.98% | -89.94% | |||
| Operating Income | -212.98% | 89.94% | |||
| Income Before Tax | -17.18% | 130.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.18% | 130.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.18% | 130.10% | |||
| EBIT | -212.98% | 89.94% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -17.15% | 173.23% | |||
| Normalized Basic EPS | -17.28% | 174.68% | |||
| EPS Diluted | -17.15% | 173.23% | |||
| Normalized Diluted EPS | -17.28% | 174.68% | |||
| Average Basic Shares Outstanding | 0.00% | -15.95% | |||
| Average Diluted Shares Outstanding | 0.00% | -15.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||